Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19

Sandhu, A., Naderi, E., Wijninga, M., Liemburg, E., Cath, D., Bruggeman, R., & Alizadeh, B. (2023). Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19. Journal of Personalized Medicine, 13(9), 1354. https://doi.org/10.3390/jpm13091354
Authors:
Amrit K Sandhu
Elnaz Naderi
Morenika J Wijninga
Edith J Liemburg
Group Investigators
Danielle Cath
Richard Bruggeman
Behrooz Z Alizadeh
Affiliated Authors:
Elnaz Naderi
Columbia Affiliation:
Author Keywords:
antipsychotic
cardiometabolic syndrome
cytochrome p450
genotyping
metabolism
pharmacodynamic
pharmacogenetic
pharmacokinetic
polygenic risk score
schizophrenia
elink
Publication Type:
Article
Unique ID:
10.3390/jpm13091354
PMID:
37763122
DOI:
10.3390/jpm13091354
Journal:
Journal of Personalized Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: